0001477932-21-000073.txt : 20210106
0001477932-21-000073.hdr.sgml : 20210106
20210106170027
ACCESSION NUMBER: 0001477932-21-000073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210106
FILED AS OF DATE: 20210106
DATE AS OF CHANGE: 20210106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heaton Kristofer
CENTRAL INDEX KEY: 0001835114
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27781
FILM NUMBER: 21511447
MAIL ADDRESS:
STREET 1: 10624 SOUTH EASTERN AVE.
STREET 2: SUITE A209
CITY: HENDERSON
STATE: NV
ZIP: 89052
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: United Health Products, Inc.
CENTRAL INDEX KEY: 0001096938
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 841517723
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10624 S. EASTERN AVE
STREET 2: STE. A209
CITY: HENDERSON
STATE: NV
ZIP: 89052
BUSINESS PHONE: (877) 358-3444
MAIL ADDRESS:
STREET 1: 10624 S. EASTERN AVE
STREET 2: STE. A209
CITY: HENDERSON
STATE: NV
ZIP: 89052
FORMER COMPANY:
FORMER CONFORMED NAME: United EcoEnergy Corp.
DATE OF NAME CHANGE: 20060224
FORMER COMPANY:
FORMER CONFORMED NAME: MNS EAGLE EQUITY GROUP III INC
DATE OF NAME CHANGE: 19991019
4
1
form4.xml
FORM 4
X0306
4
2021-01-06-05:00
false
0001096938
United Health Products, Inc.
UEEC
0001835114
Heaton Kristofer
10624 SOUTH EASTERN AVE.
SUITE A209
HENDERSON
NV
89052
false
true
false
false
Principal Financial Officer
Common Stock
2021-01-06-05:00
4
A
false
100000
1.04
A
405000
D
Restricted Stock Unit Awards
2021-01-06-05:00
4
J
false
100000
D
Common Stock
500000
825000
D
In December 2020, Mr. Heaton was granted 500,000 restricted stock unit awards ("RSUs") bringing his total to 925,000. The new 500,000 restricted stock unit awards vest upon performance and do not contain a conversion or exercise price or any time constraints. 5% of the RSUs vest upon FDA approval of the company's Class III PMA, an additional 10% of the RSUs will vest upon the execution of each commercial distribution agreement from the marketing of its products, up to a maximum of three such agreements and the balance will vest upon the company achieving $30 million in gross cumulative sales or a covered transaction as defined in the agreement. Prior to December 2020 and prior to Mr. Heaton becoming VP-Finance, Mr. Heaton was granted 500,000 RSUs, which included 75,000 which vested in July 2020. An additional 75,000 RSUs vest upon FDA approval of the Company's Class III PMA, an additional 100,000 RSUs will vest on January 1, 2021 and the balance will vest upon the Company achieving $20,000,000 in gross cumulative sales or a covered transaction or a trigger event as defined in the agreement.
Not applicable.
Excludes RSU's in Table II.
100,000 RSU's vested as described in footnote (1).
/s/ Kristofer Heaton
2021-01-06-05:00